Cigna Investments’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-21,000
Closed -$143K 771
2020
Q2
$143K Buy
+21,000
New +$136K 0.01% 716
2019
Q1
Sell
-39,435
Closed -$380K 784
2018
Q4
$380K Sell
39,435
-570
-1% -$6.36K 0.03% 425
2018
Q3
$477K Sell
40,005
-72,825
-65% -$990K 0.04% 376
2018
Q2
$1.35M Sell
112,830
-1,100
-1% -$13.6K 0.1% 186
2018
Q1
$1.41M Buy
113,930
+96,244
+544% +$1.37M 0.09% 177
2017
Q4
$259K Buy
+17,686
New +$246K 0.02% 745

Other funds holding MDRX

Cigna Investments's MDRX Position: Q3 2020 in Review

Cigna Investments sold out of Veradigm Inc. Common Stock (MDRX) in Q3 2020, closing a stake of 21,000 shares — an estimated $143K sold.

Cigna Investments first reported a position in MDRX in Q4 2017 and held it in 6 quarters. The position peaked at $1.41M in Q1 2018. 203 funds tracked by Wall St. Rank hold MDRX as of Q3 2020.

  • Cigna Investments reported no remaining Veradigm Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Cigna Investments sold 21,000 Veradigm Inc. Common Stock shares in Q3 2020, an estimated $143K.
  • Cigna Investments first reported a position in Veradigm Inc. Common Stock in Q4 2017 and held it in 6 quarters.
  • Cigna Investments's Veradigm Inc. Common Stock position peaked at $1.41M in Q1 2018.
  • 203 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q3 2020.

Based on Cigna Investments's 13F filing for Q3 2020, filed 12 Nov 2020.